Astrana Health, Inc. (NASDAQ:ASTH) Stock Has Average Price Target of $49.88

Astrana Health, Inc. (NASDAQ:ASTH) has earned an average rating of “Moderate Buy” from the ten research firms that are presently covering the company, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $49.88.

A number of equities research analysts recently weighed in on ASTH shares. TD Cowen lifted their price objective on shares of Astrana Health from $45.00 to $50.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. BTIG Research increased their price objective on shares of Astrana Health from $50.00 to $65.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Wall Street Zen lowered shares of Astrana Health from a “buy” rating to a “hold” rating in a research note on Sunday, August 16th. Barclays upped their target price on Astrana Health from $50.00 to $53.00 and gave the stock an “overweight” rating in a research report on Friday, August 7th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Astrana Health in a research report on Thursday, August 27th.

Astrana Health Stock Performance

ASTH opened at $38.40 on Thursday. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 1.05. The business’s 50 day moving average is $37.10 and its 200-day moving average is $37.25. The stock has a market cap of $2.14 billion, a PE ratio of 46.83 and a beta of 1.03. Astrana Health has a twelve month low of $18.08 and a twelve month high of $51.60.

Astrana Health (NASDAQ:ASTH) last posted its earnings results on Thursday, August 6th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.34 by $0.46. Astrana Health had a return on equity of 10.30% and a net margin of 1.05%. The firm had revenue of $972.52 million for the quarter, compared to analysts’ expectations of $985.62 million. During the same period last year, the firm earned $0.19 EPS. The firm’s revenue was up 48.5% compared to the same quarter last year. On average, analysts predict that Astrana Health will post 1.36 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of ASTH. Sei Investments Co. boosted its position in shares of Astrana Health by 94.4% during the 1st quarter. Sei Investments Co. now owns 134,899 shares of the company’s stock valued at $3,308,000 after purchasing an additional 65,509 shares in the last quarter. Bank of New York Mellon Corp bought a new stake in Astrana Health during the second quarter worth approximately $10,902,000. Bank of America Corp DE grew its position in Astrana Health by 13.3% in the first quarter. Bank of America Corp DE now owns 574,729 shares of the company’s stock worth $14,092,000 after buying an additional 67,628 shares during the last quarter. Principal Financial Group Inc. grew its position in Astrana Health by 15.7% in the first quarter. Principal Financial Group Inc. now owns 265,948 shares of the company’s stock worth $6,521,000 after buying an additional 36,150 shares during the last quarter. Finally, Diamond Hill Capital Management LLC Investment Advisor bought a new position in shares of Astrana Health in the second quarter valued at $22,088,000. 52.77% of the stock is owned by institutional investors and hedge funds.

Astrana Health Company Profile

Astrana Health, Inc is a healthcare enablement company that helps physicians and other healthcare providers deliver coordinated, value-based care. The company works with medical groups, independent physician associations and healthcare organizations to manage patient populations, improve clinical outcomes and coordinate services across primary, specialty and post-acute care settings.

Astrana Health provides care-management programs, population-health analytics, technology solutions and administrative support designed to help providers manage risk-based reimbursement arrangements.